Development
Cardio Diagnostics Holdings, Inc.
CDIO
$4.77
$0.2455.42%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 12.70K | 2.70K | 1.00K | 1.00K | 900.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.70K | 2.70K | 1.00K | 1.00K | 900.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 12.70K | 2.70K | 1.00K | 1.00K | 900.00 |
| SG&A Expenses | 7.90M | 7.64M | 5.88M | 4.49M | 2.39M |
| Depreciation & Amortization | 18.40K | 17.60K | 16.80K | 16.00K | 16.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.09M | 7.79M | 6.02M | 4.55M | 2.36M |
| Operating Income | -8.08M | -7.79M | -6.02M | -4.55M | -2.36M |
| Income Before Tax | -9.37M | -8.58M | -5.40M | -4.66M | -2.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.37 | -8.58 | -5.40 | -4.66 | -2.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.37M | -8.58M | -5.40M | -4.66M | -2.47M |
| EBIT | -8.08M | -7.79M | -6.02M | -4.55M | -2.36M |
| EBITDA | -8.02M | -7.77M | -6.00M | -4.53M | -2.35M |
| EPS Basic | -0.98 | -0.99 | -0.75 | -0.71 | -0.54 |
| Normalized Basic EPS | -0.59 | -0.59 | -0.46 | -0.43 | -0.32 |
| EPS Diluted | -0.98 | -0.99 | -0.75 | -0.71 | -0.54 |
| Normalized Diluted EPS | -0.59 | -0.59 | -0.46 | -0.43 | -0.32 |
| Average Basic Shares Outstanding | 39.32M | 34.03M | 29.22M | 23.89M | 17.58M |
| Average Diluted Shares Outstanding | 39.32M | 34.03M | 29.22M | 23.89M | 17.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |